ARCHIVES

Rauscher Responds To Criticism

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics

September 28, 1979

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002